Cluster 1 was enriched with hormone receptor‐negative (e.g., ER‐, PgR‐, and HER2‐) and samples with high TILs, which suggests that microRNAs detected in the interstitium are associated with breast tumor subtype, as well as immune response. This evidence concerns the gene ERBB2 and breast neoplasm.